CLINICAL_TRIALS
trial_result
· 2024-07-09
Clinical Trial Update: A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis [Phase 1, Phase 2]
Summary
A Phase 1/2 trial evaluating BGT-002 tablets for nonalcoholic steatohepatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Burgeon Therapeutics Co., Ltd. | Conditions: NASH | Phase 1, Phase 2 | Status: COMPLETED